Delivery Order SPE2DB20D3103-SPE2DB23FL7R6
Award Date 12/1/22
Potential Completion Date 12/2/22
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,272.40 firm-fixed-price delivery order is for the provision of 4566378192 Adacel TDAP syringes. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a $1,742.00 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADACEL TDAP SYRINGE 5S, a medical supply item, with a completion date of July 3, 2025. The award is under a Firm Fixed Price contract type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.23 firm-fixed-price contract is for the supply of ADACEL TDAP VIAL 0.5ML, a vaccine product, with a period of performance through February 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Adacel TDAP syringes. The order, valued at $27,192.00, is a firm-fixed-price contract with a completion date of July 26, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,692.40 firm-fixed-price contract is for the delivery of ADACEL TDAP SYRINGE 0.5ML, a vaccine product. The award has a period of performance through September 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for ADACEL TDAP SYRINGE 0.5ML, with a firm fixed price of $26,800.00 and a period of performance through June 26, 2025. The contract is not set aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Adacel Tdap syringes in 0.5 mL quantities. The $15,784.80 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that serves as a critical supplier to federal healthcare programs. The contract has an ultimate completion date of July 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $71,498.26, is for the delivery of ADACEL TDAP SYRINGE 0.5ML medical supplies. The contract is a firm fixed-price delivery order with a period of performance through May 17, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ADACEL TDAP SYRINGE 0.5ML. The firm-fixed-price contract, valued at $1,340.00, has a completion date of June 13, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,757.06 firm fixed price contract is for the delivery of ADACEL TDAP syringes. The contract has an ultimate completion date of April 9, 2024 and was awarded on April 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL7R6Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559241095 Adacel TDAP syringes (0.5 mL). The $14,298.10 firm-fixed-price delivery order has a period of performance through December 2, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Generated 2/27/25, 12:18 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 12/1/22 |